Marco Investment Management LLC Sells 13,460 Shares of CVS Health Co. (NYSE:CVS)

Marco Investment Management LLC trimmed its position in CVS Health Co. (NYSE:CVS) by 8.5% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 145,198 shares of the pharmacy operator’s stock after selling 13,460 shares during the period. Marco Investment Management LLC’s holdings in CVS Health were worth $11,465,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of the company. Atticus Wealth Management LLC increased its holdings in CVS Health by 149.0% in the fourth quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock valued at $29,000 after purchasing an additional 219 shares during the period. Cornerstone Planning Group LLC increased its holdings in CVS Health by 111.5% in the third quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 243 shares during the period. ZRC Wealth Management LLC increased its holdings in CVS Health by 400.0% in the fourth quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock valued at $39,000 after purchasing an additional 400 shares during the period. Coston McIsaac & Partners increased its holdings in CVS Health by 42.6% in the fourth quarter. Coston McIsaac & Partners now owns 539 shares of the pharmacy operator’s stock valued at $42,000 after purchasing an additional 161 shares during the period. Finally, Tennessee Valley Asset Management Partners acquired a new stake in CVS Health in the fourth quarter valued at $50,000. 80.66% of the stock is currently owned by institutional investors.

Insider Activity at CVS Health

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of CVS Health stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the transaction, the executive vice president now owns 39,765 shares of the company’s stock, valued at approximately $3,059,916.75. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.24% of the stock is owned by insiders.

CVS Health Stock Down 0.2 %

NYSE CVS traded down $0.15 during trading hours on Friday, hitting $67.18. The company’s stock had a trading volume of 6,396,438 shares, compared to its average volume of 8,376,818. CVS Health Co. has a 52 week low of $64.41 and a 52 week high of $83.25. The company has a market capitalization of $84.68 billion, a PE ratio of 10.40, a price-to-earnings-growth ratio of 0.89 and a beta of 0.52. The company has a current ratio of 0.86, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. The company’s 50-day simple moving average is $74.42 and its two-hundred day simple moving average is $73.67.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share for the quarter, beating the consensus estimate of $2.01 by $0.11. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The business had revenue of $93.81 billion for the quarter, compared to analysts’ expectations of $90.58 billion. During the same quarter last year, the firm earned $1.99 EPS. The firm’s revenue for the quarter was up 11.9% compared to the same quarter last year. Research analysts anticipate that CVS Health Co. will post 8.31 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 1st. Investors of record on Monday, April 22nd will be given a $0.665 dividend. The ex-dividend date is Friday, April 19th. This represents a $2.66 annualized dividend and a yield of 3.96%. CVS Health’s payout ratio is 41.18%.

Analyst Ratings Changes

A number of analysts recently weighed in on the company. Piper Sandler increased their price objective on CVS Health from $93.00 to $94.00 and gave the company an “overweight” rating in a report on Friday, March 15th. Royal Bank of Canada decreased their price target on CVS Health from $86.00 to $84.00 and set an “outperform” rating for the company in a report on Thursday, February 8th. Wells Fargo & Company decreased their price target on CVS Health from $83.00 to $76.00 and set an “equal weight” rating for the company in a report on Monday, April 8th. StockNews.com downgraded CVS Health from a “buy” rating to a “hold” rating in a report on Thursday, February 15th. Finally, Barclays assumed coverage on CVS Health in a report on Wednesday, March 6th. They set an “equal weight” rating and a $78.00 price target for the company. Four analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $89.44.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.